T1	Participants 126 158	Patients With Metabolic Syndrome
T2	Participants 355 427	patients with metabolic syndrome, with and without stable statin therapy
T3	Participants 482 514	patients with metabolic syndrome
T4	Participants 843 896	placebo in patients with metabolic syndrome in MARINE
T5	Participants 1108 1148	patients with and without statin therapy
T6	Participants 1847 1879	patients with metabolic syndrome
